For Toxic Epidermal Necrolysis, what is the initial management?

Study for the PaEasy Emergency Medicine Test. Prepare with detailed questions and explanations. Get ready to ace your exam!

Multiple Choice

For Toxic Epidermal Necrolysis, what is the initial management?

Explanation:
Toxic epidermal necrolysis is a life-threatening reaction with widespread skin detachment and mucous membrane involvement, behaving like a massive burn injury. The first priority is to place the patient in an ICU or burn unit where intensive monitoring and multidisciplinary care are available. This setting supports aggressive fluid and electrolyte management, temperature and wound care, pain control, nutrition, and prevention of infection, all crucial because massive skin loss leads to rapid fluid shifts, temperature instability, infection risk, and potential organ failure. An emergent dermatology consult is essential to confirm the diagnosis, identify and stop the offending drug, guide wound care strategies, and help determine if any immunomodulatory therapies are appropriate in the specific case. Outpatient antihistamines won’t address the ongoing fluid losses, wound care needs, or risk of sepsis. Topical steroids alone are insufficient for such extensive disease and do not replace the need for systemic supportive care. Home rest is not appropriate given the potential for rapid deterioration and the high stakes involved in TEN management.

Toxic epidermal necrolysis is a life-threatening reaction with widespread skin detachment and mucous membrane involvement, behaving like a massive burn injury. The first priority is to place the patient in an ICU or burn unit where intensive monitoring and multidisciplinary care are available. This setting supports aggressive fluid and electrolyte management, temperature and wound care, pain control, nutrition, and prevention of infection, all crucial because massive skin loss leads to rapid fluid shifts, temperature instability, infection risk, and potential organ failure. An emergent dermatology consult is essential to confirm the diagnosis, identify and stop the offending drug, guide wound care strategies, and help determine if any immunomodulatory therapies are appropriate in the specific case.

Outpatient antihistamines won’t address the ongoing fluid losses, wound care needs, or risk of sepsis. Topical steroids alone are insufficient for such extensive disease and do not replace the need for systemic supportive care. Home rest is not appropriate given the potential for rapid deterioration and the high stakes involved in TEN management.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy